Denali Therapeutics, Inc. (DNLI)
20.49
+0.77
(+3.90%)
USD |
NASDAQ |
Sep 21, 16:00
20.49
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics Total Return Price : 20.49 for Sept. 21, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| September 18, 2026 | 19.72 |
| September 17, 2026 | 20.13 |
| September 16, 2026 | 20.06 |
| September 15, 2026 | 20.38 |
| September 14, 2026 | 21.22 |
| September 11, 2026 | 21.09 |
| September 10, 2026 | 21.40 |
| September 09, 2026 | 21.57 |
| September 08, 2026 | 22.08 |
| September 04, 2026 | 22.28 |
| September 03, 2026 | 22.80 |
| September 02, 2026 | 22.85 |
| September 01, 2026 | 23.26 |
| August 31, 2026 | 23.76 |
| August 28, 2026 | 24.00 |
| August 27, 2026 | 24.67 |
| August 26, 2026 | 24.57 |
| August 25, 2026 | 24.93 |
| August 24, 2026 | 24.20 |
| August 21, 2026 | 24.92 |
| August 20, 2026 | 24.95 |
| August 19, 2026 | 25.69 |
| August 18, 2026 | 24.31 |
| August 17, 2026 | 24.35 |
| August 14, 2026 | 24.40 |
| Date | Value |
|---|---|
| August 13, 2026 | 24.82 |
| August 12, 2026 | 25.27 |
| August 11, 2026 | 24.69 |
| August 10, 2026 | 25.00 |
| August 07, 2026 | 24.83 |
| August 06, 2026 | 24.73 |
| August 05, 2026 | 24.42 |
| August 04, 2026 | 24.17 |
| August 03, 2026 | 23.15 |
| July 31, 2026 | 23.02 |
| July 30, 2026 | 24.35 |
| July 29, 2026 | 23.85 |
| July 28, 2026 | 24.05 |
| July 27, 2026 | 23.57 |
| July 24, 2026 | 23.11 |
| July 23, 2026 | 23.42 |
| July 22, 2026 | 23.64 |
| July 21, 2026 | 23.83 |
| July 20, 2026 | 22.90 |
| July 17, 2026 | 23.29 |
| July 16, 2026 | 22.73 |
| July 15, 2026 | 23.02 |
| July 14, 2026 | 22.65 |
| July 13, 2026 | 26.48 |
| July 10, 2026 | 25.68 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 68.80 |
| Oncolytics Biotech, Inc. | 0.7679 |
| Sangamo Therapeutics, Inc. | 0.1449 |
| Sarepta Therapeutics, Inc. | 20.13 |
| Anixa Biosciences, Inc. | 2.70 |